BIF
BIF.NZXNo earnings data available yet for BIF.
Recent Announcements
BIF Amended Statement of Investment Policy and Objectives
Booster Innovation Fund (managed by Booster Investment Management Limited) has amended its Statement of Investment Policy and Objectives effective 22 May 2026 (Version 26.0). The fund invests in a diversified portfolio of early-stage New Zealand companies with IP-based origins, targeting returns that outperform the NZX 50 Index over 15-year periods through partnerships, diversification, and co-investment strategies.
BIF - Valuation Update
Booster Investment Management Limited has decreased the net asset value of the Booster Innovation Fund by $719,000 (2.8%) to $1.52 per unit, following a portfolio company's capital raise at a lower valuation than previously reflected in the Fund's holdings. The valuation adjustment takes effect in the unit price issued on 15 May 2026.
BIF - Update on Senior Managers
Booster Investment Management Limited (BIML) announced that Allan Yeo stepped down as a director of Booster Financial Services Limited effective 4 May 2026 and is no longer deemed a Senior Manager of BIML, following a December 2025 group structure change. The announcement lists the updated Board of Directors (5 members including CEO Di Papadopoulos) and Senior Managers (6 members) of BIML.
BIF - SPH Movement Notice
Booster-related entities (Booster KiwiSaker Scheme, Booster Investment Scheme, Booster SuperScheme, and Asset Custodian Nominees Ltd) disclosed a movement in their substantial holding of Booster Innovation Fund (BIF) ordinary units, with their combined holding increasing from 96.909% to 97.208% as of 1 May 2026, primarily through various unit purchases directly from the Fund between October 2025 and May 2026.
BIF – Quarterly Client Update – 31 March 2026
The Booster Innovation Fund reported positive Q1 2026 performance with a 4.9% quarterly return and 10.2% p.a. since inception, holding $25.4m across 35+ portfolio companies. The fund made follow-on investments in Wellumio (portable brain scan technology) and Scentian Bio (AI-powered biosensors), while portfolio highlights included Mars Bioimaging's FDA clearance for a photon-counting CT scanner and Nutrition from Water's partnership with a Chinese pharmaceutical company to scale production.
BIF D&O Ongoing Disclosure of Relevant Interests
Allan Seng Teng Yeo, Senior Manager of Booster Investment Management Limited, disclosed three transactions on 1 April 2026 involving Booster Innovation Fund ordinary units: an issue of 62,794 units ($97,500), an on-market purchase of 65,000 units ($100,783), and a redemption of 65,000 units ($100,926), resulting in a net increase in holdings from 2,974,069 to 3,036,862 units.
BIF - On market repurchase of units
BIF's manager, Booster Investment Management Limited, announced an on-market repurchase of up to 65,000 BIF units on the NZX on 1 April 2026 at a price not exceeding net asset value, with the units to be subsequently redeemed. This repurchase addresses net selling activity in recent months and will be executed by Booster Financial Services Limited (the manager's parent company).
BIF - Valuation Update
Booster Innovation Fund has increased its net asset value by $629,000 (2.6%) to $1.534 per unit following a third-party capital raise at one of its portfolio companies at a price substantially higher than the current carrying value. The Fund may see an additional 3.8% increase if the transaction completes as anticipated, though completion uncertainty remains.
Get real-time alerts for BIF
Receive AI-powered earnings summaries and instant notifications when BIF releases results.
Register Free